Dear reader of ADxS.org, please excuse the disruption.

ADxS.org needs about $63500 in 2024. In 2023 we received donations of about $ 32200. Unfortunately, 99.8% of our readers do not donate. If everyone who reads this request makes a small contribution, our fundraising campaign for 2024 would be over after a few days. This donation request is displayed 23,000 times a week, but only 75 people donate. If you find ADxS.org useful, please take a minute and support ADxS.org with your donation. Thank you!

Since 01.06.2021 ADxS.org is supported by the non-profit ADxS e.V..

$8975 of $63500 - as of 2024-02-29
14%
Header Image
Evidence levels, recommendation levels

Evidence levels, recommendation levels

1. Increments of evidence

Increment Type Max. risk of bias
1++ High-quality meta-analyses, systematic reviews of RCTs or RCTs Very low risk of bias
1+ Well-conducted meta-analyses, systematic reviews of RCTs or RCTs Low risk of bias
1 Meta-analyses, systematic reviews of RCTs or RCTs High risk of bias
2+ Well-conducted case-control or cohort studies Low risk of confounding, bias or chance and at least a medium probability that the association is causal
2 Case-control or cohort studies high risk of confounding, bias or chance and at least a significant risk that the association is not causal
3 Non-analytical studies, e.g. case reports, case series
4 Expert opinion

2. Increments of the recommendation

Increment Recommendation
A At least one meta-analysis, systematic review or RCT that has been rated 1++ and is directly applicable to the target population;
or a systematic review of RCTs or a body of evidence consisting primarily of studies that are rated 1+, are directly applicable to the target population, and have overall consistency of results
B A body of evidence that includes studies that are rated 2++, are directly applicable to the target population, and demonstrate overall agreement of results
or extrapolated evidence from studies rated 1++ or 1+
C Body of evidence includes studies rated 2+ that are directly applicable to the target population and whose results are consistent overall
or extrapolated evidence from studies rated 2++
D Evidence level 3 or 4
or extrapolated evidence from studies rated 2+
Diese Seite wurde am 13.04.2024 zuletzt aktualisiert.